ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years
Huanyu Wang
Matched on ORCID iD 0000-0001-6245-2027; OpenAlex author ID A5100696523. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 25
2018: 2 papers · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 6
- Molecular Imaging: Unveiling Metabolic Abnormalities in Pancreatic Cancer. Co-author DOI 10.3390/ijms26115242↗
- Development and validation of a nomogram model based on pretreatment ultrasound and contrast-enhanced ultrasound to predict the efficacy of neoadjuvant chemoth… Co-author DOI 10.1186/s40644-024-00662-2↗
- PYCR1: A Potential Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.7150/jca.61498↗
- Integrated analysis of gene expression and methylation profiles of novel pancreatic cancer cell lines with highly metastatic activity. First author DOI 10.1007/s11427-018-9495-2↗
- Gemcitabine exhibits a suppressive effect on pancreatic cancer cell growth by regulating processing of PVT1 to miR1207. First author DOI 10.1002/1878-0261.12393↗
- Tumor microenvironment participates in metastasis of pancreatic cancer. Co-author DOI 10.1186/s12943-018-0858-1↗
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ke Lv · 2 shared papers, 2024–2025 · strength 0.61
- Gang Yang · 3 shared papers, 2018–2019 · strength 0.27
- Paper Integrated analysis of gene expression and methylation profiles of novel pancreatic cancer cell lines with highly metas… DOI 10.1007/s11427-018-9495-2↗
- Paper Tumor microenvironment participates in metastasis of pancreatic cancer. DOI 10.1186/s12943-018-0858-1↗
- Paper Gemcitabine exhibits a suppressive effect on pancreatic cancer cell growth by regulating processing of PVT1 to miR1207. DOI 10.1002/1878-0261.12393↗
- Yupei Zhao · 3 shared papers, 2018–2019 · strength 0.27
- Paper Integrated analysis of gene expression and methylation profiles of novel pancreatic cancer cell lines with highly metas… DOI 10.1007/s11427-018-9495-2↗
- Paper Tumor microenvironment participates in metastasis of pancreatic cancer. DOI 10.1186/s12943-018-0858-1↗
- Paper Gemcitabine exhibits a suppressive effect on pancreatic cancer cell growth by regulating processing of PVT1 to miR1207. DOI 10.1002/1878-0261.12393↗
- Lei You · 3 shared papers, 2018–2019 · strength 0.27
- Paper Integrated analysis of gene expression and methylation profiles of novel pancreatic cancer cell lines with highly metas… DOI 10.1007/s11427-018-9495-2↗
- Paper Tumor microenvironment participates in metastasis of pancreatic cancer. DOI 10.1186/s12943-018-0858-1↗
- Paper Gemcitabine exhibits a suppressive effect on pancreatic cancer cell growth by regulating processing of PVT1 to miR1207. DOI 10.1002/1878-0261.12393↗
- Mengyu Feng · 2 shared papers, 2018–2019 · strength 0.19
- Yuming Shao · 1 shared paper, 2024 · strength 0.18
- Xiaoyi Yan · 1 shared paper, 2024 · strength 0.18
- Yuejuan Cheng · 1 shared paper, 2024 · strength 0.18
- Menghua Dai · 1 shared paper, 2024 · strength 0.18
- Weibin Wang · 1 shared paper, 2024 · strength 0.18
- Taiping Zhang · 2 shared papers, 2018–2019 · strength 0.18
- Paper Integrated analysis of gene expression and methylation profiles of novel pancreatic cancer cell lines with highly metas… DOI 10.1007/s11427-018-9495-2↗
- Paper Gemcitabine exhibits a suppressive effect on pancreatic cancer cell growth by regulating processing of PVT1 to miR1207. DOI 10.1002/1878-0261.12393↗
- Wenhui Lou · 1 shared paper, 2022 · strength 0.15
- Xuefeng Xu · 1 shared paper, 2022 · strength 0.15
- Yefei Rong · 1 shared paper, 2022 · strength 0.15
- Dansong Wang · 1 shared paper, 2022 · strength 0.15
- Lei Zhang · 1 shared paper, 2022 · strength 0.15
- Weilin Mao · 1 shared paper, 2022 · strength 0.15
- Dayong Jin · 1 shared paper, 2022 · strength 0.15
- Tiantao Kuang · 1 shared paper, 2022 · strength 0.15
- Wenchuan Wu · 1 shared paper, 2022 · strength 0.15
- Ming Cui · 1 shared paper, 2018 · strength 0.09
- Bo Xu Ren · 1 shared paper, 2018 · strength 0.09
- Fangyu Zhao · 1 shared paper, 2018 · strength 0.08
- Ziwen Liu · 1 shared paper, 2018 · strength 0.08
- Zhiyong Liang · 1 shared paper, 2018 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.